AbbVie Tokenized Stock (Reality) RABBV
Rank: 9116RABBV Price
$ 276.07
+1.42% ($ 3.85)
Price Range
- Low
- 24H
- High
- $ 270.24
- $ 277.36
General Info
Contracts/Explorers
-
Arbitrum One
0x8c9...80d91
-
Morph L2
0x0a5...efad6
- https://arbiscan.io/token/0x8c9869577b7c75220eba236dc797a66dbc780d91
- https://intel.arkm.com/explorer/token/
- https://morphl2.socialscan.io/token/0x0a5fff112aec59aeff284bb24bbf979f691efad6
- https://intel.arkm.com/explorer/token/abbvie-rstock
- https://explorer.morphl2.io/token/0x0a5fff112aec59aeff284bb24bbf979f691efad6
Categories
AbbVie Tokenized Stock (Reality) Info
AbbVie Tokenized Stock (Reality) (RABBV) Chart
RABBV Price Statistics
Market Cap
$ 13.07K
FDV
$ 13.07K
Volume (24h)
$ 149.75
Total Supply
RABBV 47.34
Circulating Supply
RABBV 47.34
(100% of Total Supply)
Max Supply
RABBV ∞
All Time High
$ 277.36 9 Oct 2026
All Time Low
$ 257.7 15 Sep 2026
About AbbVie Tokenized Stock (Reality) (RABBV)
AbbVie Inc. is a research-driven global biopharmaceutical powerhouse fortified by extensive intellectual property moats in immunology, oncology, and neuroscience. The corporation owns major blockbuster pipelines including Skyrizi and Rinvoq—the designated successors to its historic multi-billion-dollar immunology anchor Humira—alongside the leading medical aesthetics franchise Botox, maintaining superior gross margins globally.
AbbVie Tokenized Stock (Reality) Markets
Showing
to
of
results
Rows